{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:33:08Z","timestamp":1789392788175,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.biopsych.2006.09.028","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T16:02:37Z","timestamp":1170691357000},"page":"538-544","source":"Crossref","is-referenced-by-count":113,"title":["Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures"],"prefix":"10.1016","volume":"61","author":[{"given":"David J.","family":"Posey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Scahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Eugene","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Z.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea N.","family":"Witwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi B.","family":"Swiezy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegeen","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre H.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2006.09.028_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01538326","article-title":"Stimulant drug effects in developmental disorders and hyperactivity: Toward a resolution of disparate findings","volume":"12","author":"Aman","year":"1982","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2006.09.028_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/cap.2005.15.116","article-title":"Medication patterns in patients with autism: Temporal, regional, and demographic influences","volume":"15","author":"Aman","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2006.09.028_bib3","first-page":"485","article-title":"The Aberrant Behavior Checklist: A behavior rating scale of the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1016\/j.biopsych.2006.09.028_bib4","first-page":"492","article-title":"Psychometric characteristics of the Aberrant Behavior Checklist","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1016\/j.biopsych.2006.09.028_bib5","series-title":"The Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.biopsych.2006.09.028_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-1781(90)90151-T","article-title":"Motor\/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability?","volume":"33","author":"Borcherding","year":"1990","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2006.09.028_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01538168","article-title":"Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children","volume":"2","author":"Campbell","year":"1972","journal-title":"J Autism Child Schizophr"},{"key":"10.1016\/j.biopsych.2006.09.028_bib8","first-page":"70","article-title":"Levodopa and levoamphetamine: A crossover study in young schizophrenic children","volume":"19","author":"Campbell","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.biopsych.2006.09.028_bib9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1176\/appi.ajp.162.6.1133","article-title":"Pervasive developmental disorders in preschool children: Confirmation of high prevalence","volume":"162","author":"Chakrabarti","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02190114","article-title":"Stereotyped and non-stereotyped behavior in rats induced by various stimulant drugs","volume":"14","author":"Fog","year":"1969","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.biopsych.2006.09.028_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/108705470100400402","article-title":"Should the diagnosis of attention deficit\/hyperactivity disorder be considered in children with pervasive developmental disorder?","volume":"4","author":"Frazier","year":"2001","journal-title":"J Atten Disord"},{"key":"10.1016\/j.biopsych.2006.09.028_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/B:JADD.0000029554.46570.68","article-title":"The comorbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: Results of a retrospective chart review","volume":"34","author":"Goldstein","year":"2004","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2006.09.028_bib13","series-title":"ECDEU Assessment Manual of Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2006.09.028_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1005548619694","article-title":"Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder","volume":"30","author":"Handen","year":"2000","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2006.09.028_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.npp.1300627","article-title":"A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism","volume":"30","author":"Hollander","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2006.09.028_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00004583-200106000-00010","article-title":"Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder","volume":"40","author":"King","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10803-006-0147-5","article-title":"Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification","volume":"36","author":"Lecavalier","year":"2006","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2006.09.028_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism Diagnostic Interview\u2014Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2006.09.028_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.55.7.633","article-title":"A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders","volume":"55","author":"McDougle","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.1996.01830110037005","article-title":"A double-blind, placebo controlled study of fluvoxamine in adults with autistic disorder","volume":"53","author":"McDougle","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib22","series-title":"Pediatric Psychopharmacology: Principles and Practice","first-page":"563","article-title":"Autistic and other pervasive developmental disorders","author":"McDougle","year":"2003"},{"key":"10.1016\/j.biopsych.2006.09.028_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","article-title":"Risperidone for the core symptom domains of autism: Results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology","volume":"162","author":"McDougle","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder","volume":"56","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/104454602760219207","article-title":"Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder","volume":"12","author":"Owley","year":"2002","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2006.09.028_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004583-199203000-00006","article-title":"Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders","volume":"31","author":"Pelham","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/cap.2006.16.599","article-title":"Open-label atomoxetine for attention-deficit\/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders","volume":"16","author":"Posey","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2006.09.028_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02179289","article-title":"Use of methylphenidate in treatment of children with autistic disorder","volume":"25","author":"Quintana","year":"1995","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2006.09.028_bib29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2006.09.028_bib30","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","article-title":"Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity","volume":"62","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0091-3057(97)00321-3","article-title":"Stereotyped behavior: Effects of d-amphetamine and methylphenidate in the young rat","volume":"58","author":"Roffman","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2006.09.028_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/cap.2006.16.589","article-title":"A prospective open trial of guanfacine in children with pervasive developmental disorders","volume":"16","author":"Scahill","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2006.09.028_bib33","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.chi.0000220854.79144.e7","article-title":"The Children\u2019s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders","volume":"45","author":"Scahill","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib34","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children\u2019s Yale-Brown Obsessive Compulsive Scale: Reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.028_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/104454604773840481","article-title":"A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders","volume":"14","author":"Stigler","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2006.09.028_bib36","series-title":"School-Based Assessments and Interventions for ADD Students","author":"Swanson","year":"1992"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306012157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306012157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T13:20:45Z","timestamp":1547040045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322306012157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0006322306012157"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2006.09.028","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}